Evidence map›Paper›PMID 41026403›Full record

ReviewJournal of endocrinological investigation2026

Vulvodynia: still a dramatically neglected condition. A position statement on pathogenetic mechanisms from the Italian Society of Andrology and Sexual Medicine (SIAMS).

Biagio Cangiano, Sarah Cipriani, Silvia Federici, Erika Limoncin, Marianna Minnetti, Irene Scavello, Nunzia Verde, Rosario Pivonello, Linda Vignozzi, Jeff Kiesner and 2 more

Abstract readReviewConsensus Statement
PubMed Publisher
In one paragraph

Review in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Biagio CangianoDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Sarah CiprianiDepartment of Experimental Clinical and Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
Silvia FedericiDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Erika LimoncinDepartment of Dynamic and Clinical Psychology, and Health Studies, Sapienza University of Rome, Rome, Italy.
Marianna MinnettiDepartment of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
Irene ScavelloAzienda Sanitaria Usl Centro, U.F.C.A.T, Florence, Italy.
Nunzia VerdeDipartimento Di Medicina Clinica E Chirurgia, Diabetologia Ed Andrologia, Unità Di Andrologia E Medicina Della Riproduzione E Della Sessualità Maschile E Femminile (FERTISEXCARES), Sezione Di Endocrinologia, Università Federico II Di Napoli, Naples, Italy.
Rosario PivonelloDipartimento Di Medicina Clinica E Chirurgia, Diabetologia Ed Andrologia, Unità Di Andrologia E Medicina Della Riproduzione E Della Sessualità Maschile E Femminile (FERTISEXCARES), Sezione Di Endocrinologia, Università Federico II Di Napoli, Naples, Italy.
Linda VignozziDepartment of Experimental Clinical and Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
Jeff KiesnerDepartment of Development and Social Psychology, University of Padova, Padua, Italy.
Emmanuele A JanniniDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Elisa MaseroliAndrology, Women's Endocrinology and Gender Incongruence Unit, Careggi Hospital University, Florence, Italy. elisamaseroli@gmail.com.ORCID http://orcid.org/0000-0002-1472-6051

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose8–10% of women experience vulvar pain. We aim to summarize the current literature on pathogenetic mechanisms of vulvodynia, and highlight its invisible nature, that often results in misdiagnosis, prolonged diagnostic process and/or inappropriate care.

methodsA comprehensive search was conducted on the main medical databases, including studies up to April 30, 2025. The statements were internally discussed, and levels of evidence were provided according to the Oxford 2011 LoE criteria.

resultsThe panel highlights the multifactorial and complex systems underlying vulvodynia, advocating for a more comprehensive and genuinely holistic evaluation of this condition. We discuss the role of vulvovaginal dysbiosis and vestibular inflammation, increased neuronal density, central sensitization, pelvic floor muscle dysfunction/hypertonicity, reduced plasma sex steroids levels, reduced expression/altered function of estrogen and androgen receptors, prolonged and early use of Combined Hormonal Contraceptives, and psychological distress, including symptoms of anxiety and depression.

conclusionVulvodynia is an often-unrecognized condition that significantly impacts a woman’s quality of life. Our understanding of its underlying mechanisms is still limited, and more research is urgently needed. These gaps in knowledge pose major challenges for the diagnosis and effective treatment of the condition.

Indexed as

Quality of LifeVulvodyniaFemaleHumansItalySocieties, MedicalCentral sensitizationChronic painHormonesNeuroinflammationVulvodynia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.